Perrigo Company PLC當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在藥品行業排名46/159位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為18.67。中期看,股價處於下降通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Perrigo Company PLC評分
相關信息
行業排名
46 / 159
全市場排名
143 / 4563
所屬行業
藥品
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看跌
Perrigo Company PLC亮點
亮點風險
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
公司代碼PRGO
公司Perrigo Company PLC
CEOLockwood-Taylor (Patrick)
網址https://www.perrigo.com/
常見問題
Perrigo Company PLC(PRGO)的當前股價是多少?
Perrigo Company PLC(PRGO)的當前股價是 15.065。
Perrigo Company PLC 的股票代碼是什麼?
Perrigo Company PLC的股票代碼是PRGO。
Perrigo Company PLC股票的52週最高點是多少?
Perrigo Company PLC股票的52週最高點是30.930。
Perrigo Company PLC股票的52週最低點是多少?
Perrigo Company PLC股票的52週最低點是12.170。
Perrigo Company PLC的市值是多少?
Perrigo Company PLC的市值是2.07B。
Perrigo Company PLC的淨利潤是多少?
Perrigo Company PLC的淨利潤為-171.80M。
現在Perrigo Company PLC(PRGO)的股票是買入、持有還是賣出?
根據分析師評級,Perrigo Company PLC(PRGO)的總體評級為持有,目標價格為18.667。